Neuropsychology Review

, Volume 20, Issue 1, pp 21–32 | Cite as

Differential Effects of Ecstasy on Short-Term and Working Memory: A Meta-Analysis

  • Claire E. Nulsen
  • Allison M. Fox
  • Geoffrey R. Hammond
Review

Abstract

Quantitative analysis of studies examining the effect of ecstasy on short-term and working memory in the verbal and visuo-spatial domain was undertaken. Thirty verbal short-term memory, 22 verbal working memory, 12 visuospatial short-term memory and 9 visuospatial working memory studies met inclusion criteria. Ecstasy users performed significantly worse in all memory domains, both in studies using drug-naïve controls and studies using polydrug controls. These results are consistent with previous meta-analytic findings that ecstasy use is associated with impaired short-term memory function. Lifetime ecstasy consumption predicted effect size in working memory but not in short-term memory. The current meta-analysis adds to the literature by showing that ecstasy use in humans is also associated with impaired working memory, and that this impairment is related to total lifetime ecstasy consumption. These findings highlight the long-term, cumulative behavioral consequences associated with ecstasy use in humans.

Keywords

Ecstasy Memory Short-term memory Working memory 

References

  1. Back-Madruga, C., Boone, K. B., Chang, L., Grob, C. S., Lee, A., Nations, H., et al. (2003). Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users. Clinical Neuropsychologist, 17, 446–459.PubMedGoogle Scholar
  2. Bedi, G., & Redman, J. (2008). Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds. Psychological Medicine, 38, 1319–1330.CrossRefPubMedGoogle Scholar
  3. Bhattachary, S., & Powell, J. H. (2001). Recreational use of 3, 4-methylenedioxymethamphetamine (MDMA) or ‘ecstasy’: evidence for cognitive impairment. Psychological Medicine, 31, 647–658.CrossRefPubMedGoogle Scholar
  4. Cantor, J., Engle, R. W., & Hamilton, G. (1991). Short-term memory, working memory, and verbal abilities: how do they relate? Intelligence, 15, 229–246.CrossRefGoogle Scholar
  5. Capela, J. P., Carmo, H., Femião, F., Bastos, M. L., Meisel, A., & Carvalho, F. (2009). Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Molecular Neurobiology, 39, 210–271.CrossRefPubMedGoogle Scholar
  6. Cohen, J. (1969). Statistical power analysis for the behavioral sciences. NY: Academic Press.Google Scholar
  7. Cole, J. C., Michailidou, K., Jerome, L., & Sumnall, H. R. (2006). The effects of stereotype threat on cognitive function in ecstasy users. Journal of Psychopharmacology, 20, 518–525.CrossRefPubMedGoogle Scholar
  8. Conway, A. R. A., Cowan, N., Bunting, M. F., Therriault, D. J., & Minkoff, S. R. B. (2002). A latent variable analysis of working memory capacity, short-term memory capacity, processing speed, and general fluid intelligence. Intelligence, 30, 163–183.CrossRefGoogle Scholar
  9. Croft, R. J., Mackay, A. J., Mills, A. T. D., & Gruzelier, J. G. H. (2001). The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology, 153, 373–379.CrossRefPubMedGoogle Scholar
  10. Curran, H. V. (2000). Is MDMA (‘Ecstasy’) neurotoxic in humans? An overview of evidence and of methodological problems in research. Neuropsychobiology, 42, 34–41.CrossRefPubMedGoogle Scholar
  11. Dafters, R. I. (2006). Chronic ecstasy (MDMA) use is associated with deficits in taskswitching but not inhibition or memory updating executive functions. Drug and Alcohol Dependence, 83, 181–184.CrossRefPubMedGoogle Scholar
  12. Daumann, J., Schnitker, R., Weidemann, J., Schnell, K., Thron, A., & Gouzoulis-Mayfrank, E. (2003). Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users. NeuroReport, 14, 1983–1987.CrossRefPubMedGoogle Scholar
  13. de Sola, S., Tarancón, T., Peña-Casanova, J., Espadaler, J. M., Langohr, K., Poudevida, S., et al. (2008). Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study. Psychopharmacology, 200, 425–437.CrossRefPubMedGoogle Scholar
  14. de Sola Llopis, S., Miguelez-Pan, M., Peña-Casanova, J., Poudevida, S., Farré, M., Pacifici, R., et al. (2008). Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study. Journal of Psychopharmacology, 22, 498–510.CrossRefPubMedGoogle Scholar
  15. D’Esposito, M., Postle, B. R., Ballard, D., & Lease, J. (1999). Maintenance versus manipulation of information held in working memory: An event-related fMRI study. Brain and Cognition, 41, 66–86.CrossRefPubMedGoogle Scholar
  16. Della Sala, S., Gray, C., Baddeley, A., Allamano, N., & Wilson, L. (1999). Pattern span: A tool for unwelding visuo-spatial memory. Neuropsychologia, 37, 1189–1199.CrossRefPubMedGoogle Scholar
  17. Engle, R. W., Tuholski, S. W., Laughlin, J. E., & Conway, A. R. A. (1999). Working memory, short-term memory, and general fluid intelligence: a latent-variable approach. Journal of Experimental Psychology: General, 128, 309–331.CrossRefGoogle Scholar
  18. Fisk, J. E., & Montgomery, C. (2009). Evidence for selective executive function deficits in ecstasy/polydrug users. Journal of Psychopharmacology, 23, 40–50.CrossRefPubMedGoogle Scholar
  19. Fisk, J. E., Montgomery, C., Murphy, P., & Wareing, M. (2004). Evidence for executive deficits among users of MDMA (Ecstasy). British Journal of Psychology, 95, 457–466.CrossRefPubMedGoogle Scholar
  20. Fox, H. C., Parrott, A. C., & Turner, J. J. D. (2001). Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug. Journal of Psychopharmacology, 15, 273–281.CrossRefPubMedGoogle Scholar
  21. Fox, H. C., McLean, A., Turner, J. J. D., Parrott, A. C., Rogers, R., & Sahakian, B. J. (2002). Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA (“ecstasy”) polydrug users. Psychopharmacology, 162, 203–214.CrossRefPubMedGoogle Scholar
  22. Golding, J. F., Groome, D. H., Rycroft, N., & Denton, Z. (2007). Cognitive performance in light current users and ex-users of ecstasy (MDMA) and controls. The American Journal of Drug and Alcohol Abuse, 33, 301–307.CrossRefPubMedGoogle Scholar
  23. Gouzoulis-Mayfrank, E., Daumann, J., Tuchtenhagen, F., Pelz, S., Becker, S., Kunert, H-J., et al. (2000). Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). Journal of Neurology, Neurosurgery & Psychiatry, 68, 719–725.CrossRefGoogle Scholar
  24. Gouzoulis-Mayfrank, E., Thimm, B., Rezk, M., Hensen, G., & Daumann, J. (2003). Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 27, 819–827.CrossRefGoogle Scholar
  25. Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, I. (2003). The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, “Ecstasy”). Pharmacological Reviews, 55, 463–508.CrossRefPubMedGoogle Scholar
  26. Halpern, J. H., Pope, H. G., Jr., Sherwood, A. R., Barry, S., Hudson, J. I., & Yurgelun-Todd, D. (2004). Residual neuropsychological effects of illicit 3, 4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug and Alcohol Dependence, 75, 135–147.CrossRefPubMedGoogle Scholar
  27. Hanson, K. L., & Luciana, M. (2004). Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use. Psychological Medicine, 34, 229–246.CrossRefPubMedGoogle Scholar
  28. Hatzidimitriou, G., McCann, U. D., & Ricaurte, G. A. (1999). Altered serotonin innervation patterns in the forebrain of monkeys treated with (6)3, 4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. The Journal of Neuroscience, 19, 5096–5107.PubMedGoogle Scholar
  29. Heffernan, T., Jarvis, H., Rodgers, J., Scholey, A. B., & Ling, J. (2001). Prospective memory, everyday cognitive failure and central executive function in recreational users of ecstasy. Human Psychopharmacology: Clinical and Experimental, 16(8), 607–612.CrossRefGoogle Scholar
  30. Kalechstein, A. D., De La Garza, R., II, Mahoney, J. J., III, Fantegrossi, W. E., & Newton, T. F. (2007). MDMA use and neurocognition: a meta-analytic review. Psychopharmacology, 189, 531–537.CrossRefPubMedGoogle Scholar
  31. Kessels, R. P. C., van den Berg, E., Ruis, C., & Brands, A. M. A. (2008). The backward span of the Corsi block-tapping task and its association with the WAIS-III digit span. Assessment, 15, 426–434.CrossRefPubMedGoogle Scholar
  32. Kirchner, W. K. (1958). Age differences in short-term retention of rapidly changing information. Journal of Experimental Psychology, 55, 352–358.CrossRefPubMedGoogle Scholar
  33. Lamers, C. T. J., Bechara, A., Rizzo, M., & Ramaekers, J. G. (2006). Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls. Journal of Psychopharmacology, 20, 302–311.CrossRefPubMedGoogle Scholar
  34. Lau, J., Ioannidis, J. P. A., & Schmid, C. H. (1997). Quantitative synthesis in systematic reviews. Annals of Internal Medicine, 127, 820–826.PubMedGoogle Scholar
  35. Laws, K. R., & Kokkalis, J. (2007). Ecstasy (MDMA) and memory function: a meta-analytic update. Human Psychopharmacology: Clinical and Experimental, 22, 381–388.CrossRefGoogle Scholar
  36. Lezak, M. (1995). Neuropsychological assessment (3rd ed.). New York: Oxford University Press.Google Scholar
  37. Luciana, M., Collins, P. F., & Depue, R. A. (1998). Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. Cerebral Cortex, 8, 218–226.CrossRefPubMedGoogle Scholar
  38. Luciana, M., Burgund, E. D., Berman, M., & Hanson, K. L. (2001). Effects of tryptophan loading on verbal, spatial and affective working memory functions in healthy adults. Journal of Psychopharmacology, 15, 219–230.CrossRefPubMedGoogle Scholar
  39. McCann, U. D., Eligulashvili, V., & Ricaurte, G. A. (2000). (±)3, 4-methylenedioxymethamphetamine (‘Ecstasy’)-induced serotonin neurotoxicity: clinical studies. Neuropsychobiology, 42, 11–16.CrossRefPubMedGoogle Scholar
  40. McCann, U. D., Mertl, M., Eligulashvili, V., & Ricaurte, G. A. (1999). Cognitive performance in (±) 3, 4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users: a controlled study. Psychopharmacology, 143, 417–425.CrossRefPubMedGoogle Scholar
  41. McCann, U. D., Peterson, S. C., & Ricaurte, G. A. (2007). The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users. Neuropsychopharmacology, 32, 1695–1706.CrossRefPubMedGoogle Scholar
  42. McCardle, K., Luebbers, S., Carter, J. D., Croft, R. J., & Stough, C. (2004). Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology, 173, 434–439.CrossRefPubMedGoogle Scholar
  43. Medina, K. L., Shear, P. K., & Corcoran, K. (2005). Ecstasy (MDMA) exposure and neuropsychological functioning: A polydrug perspective. Journal of the International Neuropsychological Society, 11, 753–765.CrossRefPubMedGoogle Scholar
  44. Montgomery, C., & Fisk, J. E. (2007). Everyday memory deficits in ecstasy-polydrug users. Journal of psychopharmacology, 21(7), 709–717.CrossRefPubMedGoogle Scholar
  45. Montgomery, C., & Fisk, J. E. (2008). Ecstasy-related deficits in the updating component of executive processes. Human Psychopharmacology: Clinical and Experimental, 23, 495–511.CrossRefGoogle Scholar
  46. Montgomery, C., Fisk, J. E., Newcombe, R., Wareing, M., & Murphy, P. N. (2005). Syllogistic reasoning performance in MDMA (Ecstasy) users. Experimental and Clinical Psychopharmacology, 13, 137–145.CrossRefPubMedGoogle Scholar
  47. Morgan, M. J. (1998). Recreational use of ‘ecstasy’ (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology, 19, 252–264.CrossRefPubMedGoogle Scholar
  48. Morgan, M. J. (1999). Memory deficits associated with recreational use of “ecstasy” (MDMA). Psychopharmacology, 141, 30–36.CrossRefPubMedGoogle Scholar
  49. Morgan, M. J. (2000). Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology, 153, 230–248.CrossRefGoogle Scholar
  50. Owen, A. M. (1997). The functional organization of working memory processes within human lateral frontal cortex: the contribution of functional neuroimaging. European Journal of Neuroscience, 9, 1329–1339.CrossRefPubMedGoogle Scholar
  51. Park, D. C., Lautenschlager, G., Hedden, T., Davidson, N. S., Smith, A. D., & Smith, P. K. (2002). Models of visuospatial and verbal memory across the adult life span. Psychology and Aging, 17(2), 299–320.CrossRefPubMedGoogle Scholar
  52. Parrott, A. C., Lees, A., Garnham, N. J., Jones, M., & Wesnes, K. (1998). Cognitive performance in recreational users of MDMA or ‘ecstasy’: evidence for memory deficits. Journal of Psychopharmacology, 12, 79–83.CrossRefPubMedGoogle Scholar
  53. Pereira, A. P. A. (2007). Assessment of memory in rehabilitation counselling. Journal of Rehabilitation, 73, 15–25.Google Scholar
  54. Pollack, I., Johnson, L. B., & Knaff, P. R. (1959). Running memory span. Journal of Experimental Psychology, 57, 137–146.CrossRefPubMedGoogle Scholar
  55. Quednow, B. B., Jessen, F., Kühn, K.-U., Maier, W., Daum, I., & Wagner, M. (2006). Memory deficits in abstinent MDMA (ecstasy) users: Neuropsychological evidence of frontal dysfunction. Journal of Psychopharmacology, 20, 373–384.CrossRefPubMedGoogle Scholar
  56. Reay, J. L., Hamilton, C., Kennedy, D. O., & Scholey, A. B. (2006). MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes. Journal of Psychopharmacology, 20, 385–388.CrossRefPubMedGoogle Scholar
  57. Reneman, L., Booij, J., Schmand, B., van den Brink, W., & Gunning, B. (2000). Memory disturbances in “Ecstasy” users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology, 148, 322–324.CrossRefPubMedGoogle Scholar
  58. Reneman, L., Lavalaye, J., Schmand, B., de Wolff, F., van den Brink, W., den Heeten, G., et al. (2001a). Cortical serotonin transporter density and verbal memory in individuals who stopped using 3, 4-methylenedioxymethamphetamine (MDMA or “Ecstasy”): Preliminary findings. Archives of General Psychiatry, 58, 901–906.CrossRefGoogle Scholar
  59. Reneman, L., Majoie, C. B. L. M., Schmand, B., van den Brink, W., & den Heeten, G. J. (2001b). Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report. Biological Psychiatry, 50, 550–554.CrossRefGoogle Scholar
  60. Reneman, L., Schilt, T., de Win, M. M., Booij, J., Schmand, B., van den Brink, W., et al. (2006). Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. Journal of Psychopharmacology, 20, 389–399.CrossRefPubMedGoogle Scholar
  61. Repovs, G., & Baddeley, A. (2006). The multi-component model of working memory: explorations in experimental cognitive psychology. Neuroscience, 139, 5–21.CrossRefPubMedGoogle Scholar
  62. Richardson, J. T. E. (2007). Measures of short-term memory: a historical review. Cortex, 43, 635–650.CrossRefPubMedGoogle Scholar
  63. Rodgers, J. (2000). Cognitive performance amongst recreational users of “ecstasy”. Psychopharmacology, 151, 19–24.CrossRefPubMedGoogle Scholar
  64. Roiser, J. P., Rogers, R. D., & Sahakian, B. J. (2007). Neuropsychological function in ecstasy users: a study controlling for polydrug use. Psychopharmacology, 189, 505–516.CrossRefPubMedGoogle Scholar
  65. Rosenthal, R. (1979). The “file drawer problem” and tolerance for null results. Psychological Bulletin, 86, 638–641.CrossRefGoogle Scholar
  66. Schifano, F., Di Furia, L., Forza, G., Minicuci, N., & Bricolo, R. (1998). MDMA (‘ecstasy’) consumption in the context of polydrug abuse: a report on 150 patients. Drug and Alcohol Dependence, 52, 85–90.CrossRefPubMedGoogle Scholar
  67. Schilt, T., De Win, M. M., Koeter, M., Jager, G., Korf, D. J., van den Brink, W., et al. (2007). Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Archives of General Psychiatry, 64, 728–736.CrossRefPubMedGoogle Scholar
  68. Thomasius, R., Zapletalova, P., Petersen, K., Buchert, R., Andresen, B., Wartberg, L., et al. (2006). Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective. Journal of Psychopharmacology, 20, 211–225.CrossRefPubMedGoogle Scholar
  69. Verbaten, M. N. (2003). Specific memory deficits in ecstasy users? The results of a meta-analysis. Human Psychopharmacology: Clinical and Experimental, 18, 281–290.CrossRefGoogle Scholar
  70. Verkes, R. J., Gijsman, H. J., Pieters, M. S. M., Schoemaker, R. C., de Visser, S., Kuijpers, M., et al. (2001). Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology, 153, 196–202.CrossRefPubMedGoogle Scholar
  71. von Geusau, N. A., Stalenhoef, P., Huizinga, M., Snel, J., & Ridderinkof, K. R. (2004). Impaired executive function in male MDMA (“ecstasy”) users. Psychopharmacology, 175, 331–341.CrossRefGoogle Scholar
  72. Wager, T. D., & Smith, E. E. (2003). Neuroimaging studies of working memory: a meta-analysis. Cognitive, Affective, & Behavioral Neuroscience, 3, 255–274.CrossRefGoogle Scholar
  73. Wareing, M., Fisk, J. E., & Murphy, P. N. (2000). Working memory deficits in current and previous users of MDMA (‘ecstasy’). British Journal of Psychology, 91, 181–188.CrossRefPubMedGoogle Scholar
  74. Wareing, M., Fisk, J. E., Murphy, P., & Montgomery, C. (2004a). Verbal working memory deficits in current and previous users of MDMA. Human Psychopharmacology: Clinical and Experimental, 19, 225–234.CrossRefGoogle Scholar
  75. Wareing, M., Murphy, P. N., & Fisk, J. E. (2004b). Visuospatial memory impairments in users of MDMA (‘ecstasy’). Psychopharmacology, 173, 391–397.CrossRefGoogle Scholar
  76. Wareing, M., Fisk, J. E., Murphy, P., & Montgomery, C. (2005). Visuo-spatial working memory deficits in current and former users of MDMA (‘ecstasy’). Human Psychopharmacology: Clinical and Experimental, 20, 115–123.CrossRefGoogle Scholar
  77. Wareing, M., Fisk, J. E., Montgomery, C., Murphy, P. N., & Chandler, M. D. (2007). Information processing speed in ecstasy (MDMA) users. Human Psychopharmacology: Clinical and Experimental, 22, 81–88.CrossRefGoogle Scholar
  78. Yip, J. T. H., & Lee, T. M. C. (2005). Effect of ecstasy use on neuropsychological function: a study in Hong Kong. Psychopharmacology, 179, 620–628.CrossRefPubMedGoogle Scholar
  79. Zakzanis, K. K., & Young, D. A. (2001). Memory impairment in abstinent MDMA (“Ecstasy”) users: a longitudinal investigation. Neurology, 56, 966–969.PubMedGoogle Scholar
  80. Zakzanis, K. K., & Campbell, Z. (2006). Memory impairment in now abstinent MDMA users and continued users: a longitudinal follow-up. Neurology, 66(5), 740–741.CrossRefPubMedGoogle Scholar
  81. Zakzanis, K. K., Young, D. A., & Campbell, Z. (2003). Prospective memory impairment in abstinent MDMA (“Ecstasy”) users. Cognitive Neuropsychiatry, 8(2), 141–153.CrossRefPubMedGoogle Scholar
  82. Zakzanis, K. K., Campbell, Z., & Jovanovski, D. (2007). The neuropsychology of ecstasy (MDMA) use: a quantitative review. Human Psychopharmacology: Clinical and Experimental, 22, 427–435.CrossRefGoogle Scholar
  83. Zaninotto, A. L. C., Bueno, O. F. A., Pradella-Hallinan, M., Tufik, S., Rusted, J., Stough, C., et al. (2009). Acute cognitive effects of donepezil in young, healthy volunteers. Human Psychopharmacology: Clinical and Experimental, 24, 453–464.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Claire E. Nulsen
    • 1
  • Allison M. Fox
    • 1
  • Geoffrey R. Hammond
    • 1
  1. 1.School of Psychology M304The University of Western AustraliaCrawleyAustralia

Personalised recommendations